Health
New study provides comparative analysis of twelve COVID-19 vaccines – News-Medical.net
A new study by Novateur Ventures provides a comparative analysis of twelve COVID-19 Vaccines that had initiated or announced the Phase III clinical trial stage…
A new study by Novateur Ventures provides a comparative analysis of twelve COVID-19 Vaccines that had initiated or announced the Phase III clinical trial stage by early November 2020. The study highlights the early successes, as well as the hurdles and barriers yet to be overcome for ending the global COVID-19 pandemic.
- messenger RNA – Moderna and Pfizer/BioNtech
- Viral Vector-based (non-replicating) Vaccines – Astra Zeneca/University of Oxford, CanSino Biologics, Gamaleya Research Institute, Johnson…
Continue Reading
-
Business18 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News14 hours agoWilliam Robinson dies aged 89
-
Noosa News15 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats
-
Noosa News14 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89